The FDA has announced an increase in fees for assessing and exporting medical devices.

The FDA Export Reform and Enhancement Act of 1996 enables manufacturers to request that the FDA issue a certification stating that their device meets certain requirements within 20 days. It also allows the FDA to charge up to $175 for each original certification.

On September 1st, 2015 the new fees for subsequent certificates will be raised from the current cost of $15 to $85 and a new formula to calculate exportation fees will be implemented.

The FDA lists three recoverable cost categories for issuing export certificates:

  1. Direct personnel for research, review, tracking, writing and assembly
  2. purchase of equipment and supplies used for tracking, processing, printing and packaging
  3. billing and collection of fees
  4. overhead and administrative support

Requests for medical device exportation documents have doubled over the last 10 years. As medical device regulation is still developing, the raised fees are attributed to a rise in demands of such certifications and higher payroll costs (FDA).

Source: FDA

Related article: How the 4.2% Medical Device User Fee Increase Impacts You

RegDesk is an A.I.-powered regulatory intelligence software that offers 24/7 access to the latest regulatory information for over 50 markets worldwide. Our platform eliminates the need for medical device companies to spend months gathering intelligence and preparing their registration applications. Through RegDesk’s centralized platform, clients can get access to product-specific registration requirements, expert answers to their most critical regulatory questions, and real-time alerts about global regulatory changes. To experience the power of RegDesk, contact us at desk@regdesk.co or visit www.regdesk.co.